575 Participants Needed

Smoking Cessation for Tobacco-Related Cancer Prevention

JK
Overseen ByJosh Kaufmann
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Emory University
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

Trial Summary

Do I need to stop taking my current medications to join the trial?

The trial information does not specify whether you need to stop taking your current medications. It focuses on creating smoke-free homes to reduce secondhand smoke exposure.

What data supports the effectiveness of the treatment Smoke-Free Home Intervention for smoking cessation?

Research shows that hospital-based smoking cessation programs, especially those led by nurses, can help people quit smoking long-term. These programs often include behavioral support and counseling, which are key components of the Smoke-Free Home Intervention.12345

Is the Smoke-Free Home Intervention safe for humans?

The Smoke-Free Home Intervention has been studied in various settings, primarily focusing on promoting smoke-free environments to help reduce smoking. There is no specific safety data mentioned, but the intervention involves counseling and creating smoke-free spaces, which are generally considered safe activities.678910

How is the Smoke-Free Home Intervention treatment different from other smoking cessation treatments?

The Smoke-Free Home Intervention is unique because it focuses on creating a smoke-free environment at home, which can be more accessible and practical for individuals who cannot attend formal programs. This approach emphasizes the importance of a supportive home environment in quitting smoking, which is different from traditional methods that often rely on pharmacological aids or structured programs.211121314

What is the purpose of this trial?

This clinical trial evaluates a smoke-free home intervention for reducing exposure to secondhand smoke from commercial tobacco in homes of participants who live in rural tribal communities. Smoke-free homes are an innovative and relatively untapped strategy for cancer prevention in rural tribal communities. Smoke-free policies, including those that target homes, can reduce exposure to secondhand smoke and support smoking cessation. Rural and racial/ethnic inequities intersect to increase tobacco-related harms among Indigenous populations. A smoke-free home program may improve the health of the household as well as impact smoking behavior among the family unit by reducing secondhand smoke exposure.

Research Team

MK

Michelle Kegler, DrPH, MPH

Principal Investigator

Emory University Hospital/Winship Cancer Institute

Eligibility Criteria

This trial is for individuals living in rural tribal communities who are interested in reducing secondhand smoke exposure from commercial tobacco in their homes. It aims to support smoking cessation and prevent tobacco-related cancer.

Inclusion Criteria

Indicate that they do not reside in a smoke-free home
Self-report as being a smoker or living with a smoker
Identify as living in an American Indian household

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants receive the smoke-free home program, consisting of mailed educational information and a coaching call

6 weeks
1 coaching call (virtual)

Follow-up

Participants are monitored for effectiveness of the smoke-free home intervention

6 months
Follow-up assessments at 3 and 6 months

Optional Extension

Participants in the control group may optionally receive the smoke-free home program after the 6 months follow-up

Treatment Details

Interventions

  • Smoke-Free Home Intervention
Trial Overview The study tests a smoke-free home intervention against best practices and survey administration to see if it can reduce secondhand smoke exposure and help people quit smoking.
Participant Groups
2Treatment groups
Experimental Treatment
Active Control
Group I: Group I (smoke-free home program)Experimental Treatment2 Interventions
Participants receive the smoke-free home program, consisting of mailed educational information about smoke-free homes at enrollment and in weeks 4 and 6, and attend one coaching call in week 2.
Group II: Group II (waitlist control)Active Control2 Interventions
Participants receive usual care on study. Participants may optionally receive the smoke-free home program following the 6 months follow-up.

Find a Clinic Near You

Who Is Running the Clinical Trial?

Emory University

Lead Sponsor

Trials
1,735
Recruited
2,605,000+

National Cancer Institute (NCI)

Collaborator

Trials
14,080
Recruited
41,180,000+

National Institutes of Health (NIH)

Collaborator

Trials
2,896
Recruited
8,053,000+

Findings from Research

The 'Staying Free' program is a research-based smoking cessation model specifically designed for hospitalized patients, highlighting the importance of utilizing hospital stays as a chance to promote quitting smoking.
Insights gained from implementing this program suggest a systematic approach is essential for effectively integrating smoking cessation interventions into clinical practice and training for healthcare providers.
Translating smoking cessation research findings into clinical practice: the "staying free" program.Miller, NH.[2019]
A study of 479 smokers receiving a comprehensive nurse-led smoking cessation intervention showed a 56.1% abstinence rate at 1 year and a 36.4% rate at 5 years, indicating that while long-term abstinence decreases, it remains relatively high.
The number of clinic visits was crucial for success; those attending fewer than 5 visits were significantly more likely to relapse, highlighting the importance of engagement in the cessation program.
Long-term effectiveness of a nurse-led smoking cessation clinic at a comprehensive cancer center.Martรญnez, C., Castellano, Y., Fu, M., et al.[2023]
Implementing a tobacco order set in a computerized order-entry system significantly improved the identification of smoking status and increased referrals for smoking counseling and nicotine replacement therapy (NRT) among admitted patients, with usage rates of 76% and 81% respectively.
The intervention led to a notable increase in the percentage of patients receiving counseling (from 0.8% to 2.1%) and NRT orders (from 1.6% to 2.5%), which also enhanced the hospital's performance on smoking cessation quality measures, demonstrating its efficacy in promoting smoking cessation in a hospital setting.
A computerized aid to support smoking cessation treatment for hospital patients.Koplan, KE., Regan, S., Goldszer, RC., et al.[2021]

References

Translating smoking cessation research findings into clinical practice: the "staying free" program. [2019]
Long-term effectiveness of a nurse-led smoking cessation clinic at a comprehensive cancer center. [2023]
A computerized aid to support smoking cessation treatment for hospital patients. [2021]
Improving the quality of care for the hospitalized tobacco user--one institution's transformational journey. [2021]
Effectiveness of hospital-based smoking cessation. [2019]
Implementing an Evidence-based Tobacco Control Program at Five 2-1-1 Call Centers: An Evaluation Using the Consolidated Framework for Implementation Research. [2023]
Expanding population-level interventions to help more low-income smokers quit: Study protocol for a randomized controlled trial. [2023]
Smoke-Free Homes and Youth Smoking Behavior in Italy: Findings From the SIDRIAT Longitudinal Study. [2018]
Cessation and reduction in smoking behavior: impact of creating a smoke-free home on smokers. [2020]
10.United Statespubmed.ncbi.nlm.nih.gov
The "Don't smoke in our home" randomized controlled trial to protect children from second-hand smoke exposure at home. [2022]
Efficacy of telephone quit-line for smokers in iran: 12 months follow up results. [2021]
12.United Statespubmed.ncbi.nlm.nih.gov
Essential elements of self-help/minimal intervention strategies for smoking cessation. [2019]
13.United Statespubmed.ncbi.nlm.nih.gov
Current approaches in smoking cessation. [2019]
[Smoking intervention program]. [2006]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceยทPrivacy PolicyยทCookiesยทSecurity